NOEL ZVONAR: Open Payments
NPI 1770885212 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,259 in 63 payments from 18 companies in 2025. Trend: 2023 $1,319 · 2024 $1,839 · 2025 $1,259
Food & beverage: $1,259
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $199 |
| UCB, Inc. | 5 | $161 |
| Organon LLC | 5 | $144 |
| Novartis Pharmaceuticals Corporation | 5 | $142 |
| ABBVIE INC. | 9 | $136 |
| Arcutis Biotherapeutics, Inc. | 4 | $91 |
| PFIZER INC. | 4 | $81 |
| Galderma Laboratories, L.P. | 2 | $46 |
| Lilly USA, LLC | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: TREMFYA, Bimzelx, VTAMA, SKYRIZI, Zoryve, CIBINQO, SPEVIGO, COSENTYX.
Industry payments across AL — which companies pay providers there.
